Cancer Trials Ireland Announces Creation of Pat Smullen Chair in Pancreatic Cancer at University College Dublin

Cancer Trials Ireland, national organisation dedicated to advancing cancer clinical trials, announced the creation of the Pat Smullen Chair

By Danielle Norton July 14, 2023 Updated January 4, 2024 6 min read

**NO FEE PIC** 07/07/2023 (L to R) Professor Michael Keane, Dean of UCD School of Medicine Eibhlín Mulroe, CEO, Cancer Trials Ireland Prof Ray McDermott, Clinical Lead, Cancer Trials Ireland & UCD/St Vincent’s Hospital Prof Risteárd Ó’Laoide, National Director, HSE National Cancer Control Programme Pictured at the launch of the Pat Smullen Chair in Pancreatic Cancer at University College Dublin. Cancer Trials Ireland will provide €900,000 in funding over five years, which will be matched by the HSE National Cancer Control Programme. After five years, UCD will take over Cancer Trials Ireland funding contribution to continue the partnership with the HSE NCCP. The new position will anchor expertise in pancreatic research in Ireland with the ambition of creating a global centre of excellence for treatment and research of this form of cancer which has one of the poorest outcomes. For more information on the work of Cancer Trials Ireland and the research funded by the Pat Smullen Pancreatic Cancer Fund, visit www.cancertrials.ie/pat-smullen.

Cancer Trials Ireland, the national organisation dedicated to advancing cancer clinical trials, has today announced the creation of the Pat Smullen Chair in Pancreatic Cancer at University College Dublin (UCD). The new position will anchor expertise in pancreatic research in Ireland with the ambition of creating a global centre of excellence for treatment and research of this form of cancer which has one of the poorest outcomes.